Workflow
Supernus Pharmaceuticals(SUPN)
icon
Search documents
Supernus Pharmaceuticals(SUPN) - 2020 Q4 - Earnings Call Transcript
2021-02-28 06:50
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2020 Earnings Conference Call February 25, 2021 4:30 PM ET Company Participants Peter Vozzo - Westwicke Partners Jack Khattar - Founder, President, CEO, Secretary & Director James Kelly - EVP & CFO Conference Call Participants David Steinberg - Jefferies David Amsellem - Piper Sandler & Co. Nicholas Rubino - Stifel, Nicolaus & Company Operator Good afternoon, and welcome to Supernus Pharmaceuticals Fourth Quarter and Full Year 2020 Financial Results Conference ...
Supernus Pharmaceuticals(SUPN) - 2020 Q4 - Earnings Call Presentation
2021-02-25 18:22
Clara, person with Parkinson's and origami hobbyist Making everyday life significantly better for people affected by neurological diseases FEBRUARY 23, 2021 © 2021 Adamas Pharmaceuticals, Inc. | All Rights Reserved. Confidential and Proprietary. Forward looking statements › Statements contained in this presentation regarding matters that may occur in the future are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including but not limited to, statement ...
Supernus Pharmaceuticals (SUPN) Investor Presentation - Slideshow
2021-01-20 23:07
| --- | --- | |------------------------------------------------------------------------------------------------|-------| | | | | | | | Supernus Pharmaceuticals | | | © 2021 Supernus Pharmaceuticals, Inc. All Rights Reserved. Overview Presentation January 2021 | | Safe Harbor Statement This presentation and other matters discussed today or answers that may be given to questions asked include forward-looking statements within the meaning of the federal securities laws. These statements, among other things, re ...
Supernus Pharmaceuticals(SUPN) - 2020 Q3 - Earnings Call Transcript
2020-11-08 12:02
Adamas Pharmaceuticals, Inc. (ADMS) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants Peter Vozzo â Investor Relations Neil McFarlane â Chief Executive Officer Vijay Shreedhar â Chief Commercial Officer Chris Prentiss â Chief Financial Officer Conference Call Participants Zachary Sachar â Piper Sandler John Boyle â William Blair Rudy Li â SVB Leerink Operator Welcome to the Adamas Pharmaceuticals Third Quarter 2020 Financial Results and Corporate Update Conference Call. At th ...
Supernus Pharmaceuticals (SUPN) Investor Presentation - Slideshow
2020-09-17 23:20
| --- | --- | |-------------------------------------------------------------------------------------------------|-------| | | | | | | | Supernus Pharmaceuticals | | | © 2020 Supernus Pharmaceuticals, Inc. All Rights Reserved. Overview Presentation September 2020 | | Safe Harbor Statement This presentation and other matters discussed today or answers that may be given to questions asked include forward-looking statements within the meaning of the federal securities laws. These statements, among other things, ...
Supernus Pharmaceuticals(SUPN) - 2020 Q2 - Earnings Call Transcript
2020-08-19 17:54
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q2 2020 Earnings Conference Call August 19, 2020 9:00 AM ET Company Participants Peter Vozzo - IR, Westwicke Jack Khattar - President and CEO Greg Patrick - Chief Financial Officer Conference Call Participants David Amsellem - Piper Sandler David Steinberg - Jefferies Annabel Samimy - Stifel Nicolaus Operator Good morning, and welcome to the Supernus Pharmaceuticals Second Quarter 2020 Financial Results Conference Call. [Operator Instructions] As a reminder, this ...